John M L Ebos

10PUBLICATIONS
20CO-AUTHORS
Tumour immunologyInnate immunityMolecular targetsPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Mar 13, 2026
Expression of Bruton's Tyrosine Kinase Reflects Immune Cells Infiltration and Cell Proliferation in Breast Cancer.

Tamrah AlRammah, Rongrong Wu, Kohei Chida

|Dec 11, 2024
Acquired resistance to PD-L1 inhibition enhances a type I IFN-regulated secretory program in tumors.

Yuhao Shi, Amber McKenery, Melissa Dolan

|Jun 19, 2024
A Senescence-Mimicking (Senomimetic) VEGFR TKI Side Effect Primes Tumor Immune Responses via IFN/STING Signaling.

Melissa Dolan, Yuhao Shi, Michalis Mastri

|May 03, 2024
Machine-learning and mechanistic modeling of metastatic breast cancer after neoadjuvant treatment.

Sebastien Benzekry, Michalis Mastri, Chiara Nicolò

|May 01, 2024
A Senescence-Mimicking (Senomimetic) VEGFR TKI Side Effect Primes Tumor Immune Responses via IFN/STING Signaling.

Melissa Dolan, Yuhao Shi, Michalis Mastri

|Oct 14, 2022
The Differential Paracrine Role of the Endothelium in Prostate Cancer Cells.

Verónica Torres-Estay, Michalis Mastri, Spencer Rosario

Pageof 2